Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study.
J Formos Med Assoc
; 122(11): 1165-1173, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37321955
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccination
/
2019-nCoV Vaccine mRNA-1273
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Journal:
J Formos Med Assoc
Journal subject:
MEDICINA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: